quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:15:13·582d
INSIDERFiling
G1 Therapeutics Inc. logo

President and CEO Bailey John E. (Jack) Jr. was granted 181,400 shares and returned 534,787 shares to the company, closing all direct ownership in the company (SEC Form 4)

GTHX· G1 Therapeutics Inc.
Health Care
Original source

Companies

  • GTHX
    G1 Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Jan 30UpdateJP Morgan$10.00
  • Jan 3UpdateNeedham$31.00
  • Nov 4UpdateJP Morgan$19.00
  • Nov 4UpdateHC Wainwright & Co.$71.00
  • Nov 4UpdateRaymond James$24.00
  • Oct 15UpdateBTIG Research$51.00

Related

  • SEC570d
    SEC Form 15-12G filed by G1 Therapeutics Inc.
  • PR580d
    Global Cancer Rates Surge as Biotech Innovators Work on New Therapies
  • INSIDER582d
    Chief Legal & People Officer Thomas Monica R. returned 138,151 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER582d
    Director Flowers Cynthia Louise returned 20,000 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER582d
    Director Secor Alicia returned 20,000 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER582d
    Chief Financial Officer Umstead John W. V returned 168,387 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER582d
    Chief Operating Officer Murdock Terry L was granted 17,900 shares and returned 124,762 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER582d
    Director Lee Jacks returned 10,000 shares to the company, closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022